Results 111 to 120 of about 14,286,320 (254)

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

open access: yesMolecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Outstanding Business Reference Sources: The 2006 Selection of Recent Titles

open access: yes, 2007
A selection of business reference sources for ...
BRASS Business Reference Sources Committee
core  

Diagnostic Reference Levels for Pediatric CT Examinations Based on Patient Size: A Meta-analysis [PDF]

open access: yesJournal of Pediatrics Review
Background: Patient dose surveys are periodically performed to evaluate whether the patient’s doses are acceptable compared to the recommended and reported diagnostic reference levels (DRLs).
Seyed Salman Zakariaee   +2 more
doaj  

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

open access: yesMolecular Oncology, EarlyView.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu   +3 more
wiley   +1 more source

Outstanding Business Reference Sources: The 2004 Selection of Recent Titles

open access: yes, 2005
A selection of business reference sources for ...
BRASS Business Reference Sources Committee
core  

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Outstanding Business Reference Sources: The 2010 Selection of Recent Titles

open access: yes, 2011
A selection of business reference sources for ...
BRASS Business Reference Sources Committee
core  

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Reference Point Formation Over Time: A Weighting Function Approach [PDF]

open access: yes
Although the concept of reference point dependent preferences has been adopted to almost all fields of behavioral economics, especially marketing and behavioral finance, we still know very little about how decision makers form their reference points ...
Baucells, Manel   +2 more
core  

Home - About - Disclaimer - Privacy